i

iNtRON Biotechnology Inc
KOSDAQ:048530

Watchlist Manager
iNtRON Biotechnology Inc
KOSDAQ:048530
Watchlist
Price: 3 675 KRW 5.91%
Market Cap: ₩125.5B

Net Margin

-113.2%
Current
Declining
by 48.9%
vs 3-y average of -64.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-113.2%
=
Net Income
₩-6.3B
/
Revenue
₩5.6B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-113.2%
=
Net Income
₩-6.3B
/
Revenue
₩5.6B

Peer Comparison

Country Company Market Cap Net
Margin
KR
iNtRON Biotechnology Inc
KOSDAQ:048530
109.7B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
389.3B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.3B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
170.5B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.2B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
88.1B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.4B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.4B USD
Loading...

Market Distribution

Lower than 94% of companies in Korea
Percentile
6th
Based on 2 632 companies
6th percentile
-113.2%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

iNtRON Biotechnology Inc
Glance View

Market Cap
125.5B KRW
Industry
Biotechnology

iNtRON Biotechnology, Inc. is a Korea-based company principally engaged in the biotechnology industry. The Company operates its business through two main divisions: genetic reagent division and molecular diagnostics division. Its genetic reagent division is involved in the research and development of reagents, which are under the brand names of Maxime and pLUG for life science research. Its molecular diagnostics division is engaged in the development and production of nucleic acid tester for infectious diseases. It also engages in the operation of veterinary antibiotic alternative business and new biopharmaceuticals development business. The Company distributes its products within domestic market and to overseas markets.

iNtRON Biotechnology Inc Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-113.2%
=
Net Income
₩-6.3B
/
Revenue
₩5.6B
What is iNtRON Biotechnology Inc's current Net Margin?

The current Net Margin for iNtRON Biotechnology Inc is -113.2%, which is below its 3-year median of -64.2%.

How has Net Margin changed over time?

Over the last 3 years, iNtRON Biotechnology Inc’s Net Margin has decreased from 60.1% to -113.2%. During this period, it reached a low of -115.5% on Jun 30, 2025 and a high of 60.1% on Aug 30, 2022.

Back to Top